We're thrilled to be working again with LUNGevity Foundation to bring you another webinar just in time for November as lung cancer awareness month. On Tuesday, November 12th, at 2 PM Eastern/11 AM Pacific, Dr. David Spigel from Sarah Cannon Cancer Center in Nashville, TN will lead us in a very timely discussion of current and future management issues in squamous cell non-small cell lung cancer (NSCLC), a subtype that comprises 20-25% of NSCLC but has historically been more known for treatments you don't offer than for specific treatment options that are especially appealing for it. Dr. Spigel is many things: a longtime friend of mine, as well as of GRACE, a terrific medical oncologist and lung cancer expert, and the Director of Clinical Research at the Sarah Cannon Cancer Center, where he has led many pivotal clinical trials that are shaping our understanding and treatment options for lung cancer over the years. He is also a gifted speaker who does a great job making complex ideas accessible.

Dr. David Spigel

For the upcoming webinar, Dr. Spigel will provide a bit of historical perspective of what we have known about squamous cell NSCLC in terms of both its biology and clinical behavior. He will also review some of the optimal treatment approaches based on data from the past 1-2 decades, including explaining why certain treatments are specifically NOT favored for squamous NSCLC.  But the excitement is around some newer therapies, ranging from conventional chemotherapy to immune-based treatments to newly identified potential selective targets that may be highly relevant and effective for this historically underserved sizable minority of the lung cancer community.

Following his presentation that will last approximately 40-45 minutes, we'll welcome questions from our live audience. As always, our webinars are free and will be made available in edited podcast form after the program is completed, but please join us for the live event.  You can sign up here: come along and learn some new things about lung cancer during lung cancer awareness month.